Monoclonal gammopathy of undetermined significance and anti-TNF-alpha treatment.
Smale
S W
SW
Lawson
T M
TM
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D000069285:Infliximab; D008297:Male; D009101:Multiple Myeloma / Q000139:chemically induced; D010265:Paraproteinemias / Q000139:chemically induced*; D011230:Precancerous Conditions / Q000139:chemically induced; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab